×
Entrez Id:
4552
Gene Symbol:
MTRR
MTRR
0.010
GeneticVariation
phenotype
LHGDN
Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
18034637
2008
×
Entrez Id:
359
Gene Symbol:
AQP2
AQP2
0.010
AlteredExpression
phenotype
LHGDN
Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII.
18515885
2008
×
Entrez Id:
7450
Gene Symbol:
VWF
VWF
0.010
AlteredExpression
phenotype
LHGDN
Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII.
18515885
2008
×
Entrez Id:
2878
Gene Symbol:
GPX3
GPX3
0.010
GeneticVariation
phenotype
LHGDN
Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3 ) gene as a risk factor for cerebral venous thrombosis .
18096833
2008
×
Entrez Id:
5739
Gene Symbol:
PTGIR
PTGIR
0.010
GeneticVariation
phenotype
LHGDN
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study.
18551041
2008
×
Entrez Id:
3952
Gene Symbol:
LEP
LEP
0.010
Biomarker
phenotype
LHGDN
Increased serum levels of leptin in retinal vein occlusion.
18679012
2008
×
Entrez Id:
64805
Gene Symbol:
P2RY12
P2RY12
0.010
GeneticVariation
phenotype
LHGDN
Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism.
17707382
2008
×
Entrez Id:
2158
Gene Symbol:
F9
F9
0.010
Biomarker
phenotype
LHGDN
The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
18647957
2008
×
Entrez Id:
183
Gene Symbol:
AGT
AGT
0.010
GeneticVariation
phenotype
LHGDN
[Study on the association between polymorphisms in angiotensinogen gene and deep venous thrombosis].
18543221
2008
×
Entrez Id:
8858
Gene Symbol:
PROZ
PROZ
0.010
GeneticVariation
phenotype
LHGDN
The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosis.
18677630
2008
×
Entrez Id:
2100
Gene Symbol:
ESR2
ESR2
0.010
GeneticVariation
phenotype
LHGDN
Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis.
17184825
2007
×
Entrez Id:
1312
Gene Symbol:
COMT
COMT
0.010
GeneticVariation
phenotype
LHGDN
We show that the COMT rs4680 variant modulates tHcy, and might be associated with venous thrombosis risk as well.
18064318
2007
TNFRSF11B
0.010
AlteredExpression
phenotype
LHGDN
Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia vera.
15630493
2005
×
Entrez Id:
1636
Gene Symbol:
ACE
ACE
0.010
GeneticVariation
phenotype
LHGDN
The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis .
14691571
2004
×
Entrez Id:
10544
Gene Symbol:
PROCR
PROCR
0.020
Biomarker
phenotype
LHGDN
Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis.
17439632
2007
×
Entrez Id:
2099
Gene Symbol:
ESR1
ESR1
0.020
GeneticVariation
phenotype
LHGDN
Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis.
17184825
2007
×
Entrez Id:
2099
Gene Symbol:
ESR1
ESR1
0.020
GeneticVariation
phenotype
LHGDN
The ER1 haplotype does not have a strong effect on the estrogen-induced changes in haemostasis and inflammation risk markers for arterial and venous thrombosis .
16478760
2006
×
Entrez Id:
10544
Gene Symbol:
PROCR
PROCR
0.020
AlteredExpression
phenotype
LHGDN
Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
15304035
2004
×
Entrez Id:
5627
Gene Symbol:
PROS1
PROS1
0.030
AlteredExpression
phenotype
LHGDN
Only relatives with free protein S levels less than the 5th percentile (< 41 IU/dL) or less than the 2.5th percentile (< 33 IU/dL) were at higher risk of first venous thrombosis compared with the upper quartile (> 91 IU/dL); annual incidence 1.20% (95% confidence interval [CI], 0.72-1.87) and 1.81% (95% CI, 1.01-2.99), respectively; adjusted hazard ratios 5.6, (95% CI, 2.7-11.5) and 11.3 (95% CI, 5.4-23.6).
18945960
2009
×
Entrez Id:
7056
Gene Symbol:
THBD
THBD
0.030
Biomarker
phenotype
LHGDN
Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
18590927
2008
×
Entrez Id:
5627
Gene Symbol:
PROS1
PROS1
0.030
GeneticVariation
phenotype
LHGDN
A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency.
17938802
2007
×
Entrez Id:
7056
Gene Symbol:
THBD
THBD
0.030
GeneticVariation
phenotype
LHGDN
Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population.
16507317
2007
×
Entrez Id:
5627
Gene Symbol:
PROS1
PROS1
0.030
GeneticVariation
phenotype
LHGDN
Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients.
16461766
2006
×
Entrez Id:
7056
Gene Symbol:
THBD
THBD
0.030
GeneticVariation
phenotype
LHGDN
Characterization of thrombomodulin gene mutations of the 5'-regulatory region.
12204814
2002
×
Entrez Id:
2161
Gene Symbol:
F12
F12
0.040
GeneticVariation
phenotype
LHGDN
Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis.
18180442
2008